Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002583261 | SCV002939064 | benign | CHARGE syndrome | 2022-09-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004965913 | SCV005554598 | uncertain significance | Inborn genetic diseases | 2024-10-20 | criteria provided, single submitter | clinical testing | The c.8320G>A (p.G2774S) alteration is located in exon 38 (coding exon 37) of the CHD7 gene. This alteration results from a G to A substitution at nucleotide position 8320, causing the glycine (G) at amino acid position 2774 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |